El Butlletí de la Recerca es fa ressò de les publicacions indexades a la Web of Science i a Scopus, però també podeu fer-nos arribar les vostres publicacions a través de l’URecerca – Gestió de la Producció Científica que trobareu al Campus Virtual.
A novel likely pathogenic germline variant in CDKN1B in a patient with MEN4 and medullary thyroid cancer
Mercè, F., Asla, Q., Illana, F., Victòria, F., Javier, H., Marta, S.,…Aulinas, A. (2025). A novel likely pathogenic germline variant … Read More
The Costs of Loneliness-related Health Consequences in Spain
Papon, V., Puntscher, S., Arvandi, M., Jahn, B., Coll-Planas, L., Litt, J.,…Rochau, U. (2024). The Costs of Loneliness-related Health Consequences … Read More
Systematic Review on the Impact of Loneliness and Social Isolation on Cardiovascular Diseases
Puntscher, S., Spagl, S., Papon, V., Arvandi, M., Jahn, B., Pitkälä, K.,… Coll-Planas, L., …Rochau, U. (2024). Systematic Review on … Read More
A Decision-Analytic Model to Evaluate the Long-term Impacts of Nature-Based Social Prescribing Against Loneliness in Spain Informed by the RECETAS Study
Papon, V., Jahn, B., Puntscher, S., Arvandi, M., Litt, J., Masó-Aguado, M.,…Rochau, U. (2024). A Decision-Analytic Model to Evaluate the … Read More
Fundamentals of lipoprotein(a) request and quantification in the clinical laboratory
Arrobas Velilla, T., Fernández Prendes, C., Amigó Grau, N., Calmarza, P., Camós Anguila, S., Candas Estébanez, B., Castro Castro, M. … Read More
The OPTIMUS International Consensus Guidance for Monitoring User-Reported Outcomes of Opioid Maintenance Treatment: a Delphi Study
Wiessing, L., Akartuna, D., Antoine, J., Banka-Cullen, P., Barbaglia, M., Belackova, V., Torrens, M., …Grp, O. S. (2025). The OPTIMUS … Read More
The Determinants of the Concentration of Superstar Firms: Cluster Analysis and Its Relationship with Economic Development and Artificial Intelligence
Bustelo, J., Miró Pérez, A., Meruvia Torrez, H. (2025). The Determinants of the Concentration of Superstar Firms: Cluster Analysis and … Read More
Validation of the Frail-VIG frailty index in geriatric population with femur fracture
Badosa-Collell, G., Trullàs, J., Moreno, C., Ruiz-Ruiz, E., & Amblàs-Novellas, J. (2025). Validation of the Frail-VIG frailty index in geriatric … Read More
Responsive mathematics teaching and mathematics teacher noticing: a systematic review in early childhood and primary education
Alsina, A., Pincheira, N., Barquero, B., Sellas, I., & Marimon-Martí, M. (2025). Responsive mathematics teaching and mathematics teacher noticing: a … Read More
Improvements in RNA and DNA nanopore sequencing allow for rapid genetic characterization of avian influenza
Perlas, A., Reska, T., Croville, G., Tarrés-Freixas, F., Guérin, J., Majó, N., & Urban, L. (2025). Improvements in RNA and … Read More
Integrated clinico-molecular analysis of gastric cancer in European and Latin American populations: LEGACY project
Dienstmann, R., Ruiz-García, E., Alsina, M., Ruiz-Pace, F., Schooten, T., Martínez-Ciarpaglini, C.,…Fleitas, T. (2025). Integrated clinico-molecular analysis of gastric cancer … Read More
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial
Bailón, L., Moltó, J., Curran, A., Cadiñanos, J., de Quirós, J., de los Santos, I.,…Brander, C., Mothe, B., Grp, A.-S. … Read More
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) + CT in HER2-negative advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GC/GEJC): RATIONALE-305 study minimum 3-year survival follow-up
Cruz-Correa, M., Oh, D., Kato, K., Tabernero, J., Bai, Y., Shi, J.,…Moehler, M. (2024). Tislelizumab (TIS) plus chemotherapy (CT) vs … Read More
Intratumoral fusobacterium as prognostic factor in early stage colorectal cancer: Results of the FUSOMAP study
Nuciforo, P., Navarro, F., Argota, I., Alonso, L., Serna, G., Barrull, J.,…Aguado, V. (2024). Intratumoral fusobacterium as prognostic factor in … Read More
Encorafenib plus cetuximab (EC) plus FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI)
Tabernero, J., Yoshino, T., Kim, T., Yaeger, R., Desai, J., Wasan, H.,…Kopetz, S. (2024). Encorafenib plus cetuximab (EC) plus FOLFIRI … Read More
GLOSSAQUA: A global dataset of size spectra across aquatic ecosystems
Ersoy, Z., Evangelista, C., Larrañaga, A., Perkins, D. M., Sánchez-Hernández, J., Chonova, T., Cunillera-Montcusí, D., García-Comas, C., García-Girón, J., de … Read More
Specularity in NeRFs: A Comparative Study of Ref-NeRF and NRFF
Barreiro, A., Marí, R., Redondo, R., Haro, G., Bosch, C., & Berga, D. (2025). Specularity in NeRFs: A Comparative Study … Read More
On uneven ground: embracing the challenges of inter-limb asymmetries and their assessment
Afonso, J., Virgile, A., Peña, J., Jordan, M., García de Alcaraz, A., Sá, M., Bishop, C. (2025). On uneven ground: … Read More